Our data suggest that, at least in the mouse with obesity-associated AHR, the heightened CCK/CCKAR signaling in the lung appears to lead to increased ASM contraction that is independent of airway inflammation as CCKAR antagonists did not alter markers of inflammation. Here, CCK is linked to obesity disorder.